Call for proposals for health data for biotech innovation leveraging the European Health Data Space

Context

This is a call for proposals for EU action grants launched by the European Health and Digital Executive Agency (HaDEA). The covered areas are health promotion and disease prevention, cancer, cardiovascular and other non-communicable diseases, health systems and healthcare workforce, digital, other activities under the EU4Health Programme (EU4H). 
The call spans over 9 different topics:
1.    EU4H-2026-SANTE-PJ-01 - Call for proposals to pilot and implement cancer screening programmes for gastric cancer (CR/CV&NCD-g-25-12)
2.    EU4H-2026-SANTE-PJ-02 - Call for proposals to pilot and implement cancer screening programmes for lung cancer (CR/CV&NCD -g-25-13)
3.    EU4H-2026-SANTE-PJ-03 - Call for proposals to pilot and implement cancer screening programmes for prostate cancer (CR/CV&NCD-g-25-14)
4.    EU4H-2026-SANTE-PJ-04 - A European flagship initiative leveraging AI and health data for cardiovascular health and related non-communicable diseases: Advancing Risk Prediction, Prevention, Treatments, Personalised Care and Rehabilitation (CR/CV&NCD-g-25-16)
5.    EU4H-2026-SANTE-PJ-05 - Call for proposals on lifelong prevention for a healthy life with focus on cardiovascular diseases (CR/CV&NCD-g-25-18)
6.    EU4H-2026-SANTE-PJ-06 - Call for proposals to support the development of a medicine pricing, reimbursement and access tracker through the EURIPID database (HS-g-25-20)
7.    EU4H-2026-SANTE-PJ-07 - Call for proposals for a programme on orphan medical devices, in particular targeting paediatric patients (HS-g-25-24)
8.    EU4H-2026-SANTE-PJ-08 - Call for proposals for health data for biotech innovation leveraging the European Health Data Space (DI-g-25-31)
9.    EU4H-2026-SANTE-PJ-09 - Call for proposals to contribute to the organisation of conferences (OA-g-25-33)
Each project application must address only one of these topics.

Goals

• Establish a multistakeholder platform linking biotech industry, data holders, healthcare providers, patient organisations, regulators, and AI Factories to share best practices and drive data-based innovation.
• Identify and prioritise the most promising AI and digital applications in biotechnology.
• Analyse key barriers to AI adoption in biotech and propose strategies to overcome them.

Target Groups

• Biotechnology companies and startups
• Research institutions and health data infrastructures
• AI developers and digital health enterprises
• Public authorities and regulators
• Patient organisations and healthcare providers 

Eligibility

In order to be eligible, the applicants (beneficiaries and affiliated entities) must:

• Be legal entities (public or private bodies)
• Be established in one of the eligible countries, i.e.: 
  • EU Member States (including overseas countries and territories (OCTs))
  • Eligible non-EU countries: listed EEA countries and countries associated to the EU4Health Programme 

Consortium Composition

The minimum requirements for the consortium composition vary according to the topic:

• At least 3 beneficiaries from 3 different eligible countries for topic 1.
• At least 5 beneficiaries from 5 different eligible countries for topic 2, 3, 4, 5, and 8.
• For topic 6:
  • At least 4 beneficiaries from 3 different eligible countries
  • .Applicants should be EURIPID members, public authorities on pricing and reimbursement of medicines.
• For topics 7 and 9 no minimum requirements are present.

Funding

The indicative project budgets for each topic are:

1. EU4H-2026-SANTE-PJ-01: € 3,000,000 – projects funded: 1
2. EU4H-2026-SANTE-PJ-02: € 7,440,000 – projects funded: 1
3. EU4H-2026-SANTE-PJ-03: € 7,440,000 – projects funded: 1
4. EU4H-2026-SANTE-PJ-04: € 20,000,000 – projects funded: 1
5. EU4H-2026-SANTE-PJ-05: € 2,000,000 – projects funded: 1
6. EU4H-2026-SANTE-PJ-06: € 750,000 – projects funded: 1
7. EU4H-2026-SANTE-PJ-07: € 300,000 - €400,000 – projects funded: 3
8. EU4H-2026-SANTE-PJ-08: € 14,386,810 – projects funded: 1
9. EU4H-2026-SANTE-PJ-09: € 200,000 – projects funded: 3

Eligible Costs

• The grant will be a budget-based mixed actual cost grant.
• The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%).
• It is possible to apply for a higher project funding rate (80%) if your project is of “exceptional utility”, as specified in the call for proposals.

Timeline

• Opening date: 23 September 2025
• Deadline date: 06 January 2026 17:00:00 Brussels time
• Evaluation period: January – March 2026
• Information on evaluation results: April – May 2026
• Project duration (maximum):
  • 36 months for topics 1, 2, 3, 5, and 7.
  • Between 24 and 36 months for topics 4, 6, 8.
  • 12 months for topic 9.